You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Clinically Isolated Syndrome (CIS)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis Trial in Bordeaux (Clinical assessment, Neuropsychological evaluation, Psychological evaluation)

Recruiting
  • Multiple Sclerosis
  • Clinical assessment
  • +3 more
  • Bordeaux, France
    CHU de Bordeaux - service de neurologie
Jun 15, 2022

Multiple Sclerosis, Clinically Isolated Syndrome (CIS) Trial in New York, Pittsburgh (Prebiotics (Prebiotin Prebiotic Fiber

Recruiting
  • Multiple Sclerosis
  • Clinically Isolated Syndrome (CIS)
  • Prebiotics (Prebiotin Prebiotic Fiber Stick Pac)
  • Probiotics (Visbiome®)
  • New York, New York
  • +1 more
Jan 5, 2022

Pregnancy Cohort in Multiple Sclerosis (MS)

Recruiting
  • Multiple Sclerosis (MS)
  • Clinically Isolated Syndrome (CIS)
    • Berlin, Germany
      Charité Universitätsmedizin Berlin
    Aug 17, 2021

    Multiple Sclerosis, Clinically Isolated Syndrome Trial in Worldwide (Ocrelizumab)

    Recruiting
    • Multiple Sclerosis
    • Clinically Isolated Syndrome
    • San Francisco, California
    • +5 more
    Aug 2, 2022

    Multiple Sclerosis Trial in France (drug, other, biological)

    Active, not recruiting
    • Multiple Sclerosis
    • Vitamin D
    • +5 more
    • Amiens Cedex 1, France
    • +32 more
    Jan 6, 2022

    Emotional Processing in Multiple Sclerosis / Clinically Isolated

    Completed
    • Multiple Sclerosis (MS)
    • Clinically Isolated Syndrome (CIS)
      • Berlin, Germany
        Charité Unversitätsmedizin Berlin; NeuroCure Clinical Research C
      Jul 15, 2020

      Clinically Isolated Syndrome, Radiologically Isolated Syndrome, Multiple Sclerosis in Children Trial in Lomme (Tear collection

      Recruiting
      • Clinically Isolated Syndrome
      • +2 more
      • Tear collection and lumbar punction
      • Lomme, France
        GHICL
      Jan 5, 2022

      Clinically Isolated Syndrome, Relapsing Remitting Multiple Sclerosis Trial in Iowa City (Therapeutic diet and lifestyle)

      Active, not recruiting
      • Clinically Isolated Syndrome
      • Relapsing Remitting Multiple Sclerosis
      • Therapeutic diet and lifestyle
      • Iowa City, Iowa
        University of Iowa
      Dec 14, 2021

      MSRV-Env Burden in Patients With Multiple Sclerosis Disease

      Completed
      • Multiple Sclerosis (MS)
      • +4 more
      • No study treatments administered - blood draws only
      • Bron cedex, France
      • +3 more
      Oct 19, 2020

      Implementation ofNovel Functional Eye-Tracking Biomarker for

      Recruiting
      • Clinically Isolated Syndrome
      • Relapsing Remitting Multiple Sclerosis
      • Eye-tracking
      • Montréal, Quebec, Canada
        Montreal Neurological Institute and Hospital
      Sep 2, 2022

      Multiple Sclerosis, Clinically Isolated Syndrome Trial in Iowa City (Immediate Autoimmune Intervention Mastery Course (AIM),

      Active, not recruiting
      • Multiple Sclerosis
      • Clinically Isolated Syndrome
      • Immediate Autoimmune Intervention Mastery Course (AIM)
      • +3 more
      • Iowa City, Iowa
        Univeristy of Iowa
      Jul 3, 2022

      Relapsing Multiple Sclerosis, Clinically Isolated Syndrome Trial in San Francisco (Ocrelizumab)

      Recruiting
      • Relapsing Multiple Sclerosis
      • Clinically Isolated Syndrome
      • San Francisco, California
        University of California San Francisco
      Apr 28, 2022

      Ocrelizumab in Breastmilk

      Active, not recruiting
      • Multiple Sclerosis
      • Clinically Isolated Syndrome
      • San Francisco, California
        University of California, San Francisco
      Mar 21, 2022

      MSPT Device in Routine Clinical Practice in Swiss Healthcare

      Recruiting
      • Multiple Sclerosis
      • Clinically Isolated Syndrome
      • MSPT
      • Bern, Switzerland
        Inselspital Bern, Ambulantes Neurozentrum
      Nov 1, 2022

      Multiple Sclerosis, Clinically Isolated Syndrome Trial in Worldwide (Ocrelizumab)

      Recruiting
      • Multiple Sclerosis
      • Clinically Isolated Syndrome
      • San Francisco, California
      • +9 more
      Aug 2, 2022

      Multiple Sclerosis, Clinically Isolated Syndrome Trial in Bordeaux (blood sample, cerebro-spinal fluid)

      Recruiting
      • Multiple Sclerosis
      • Clinically Isolated Syndrome
      • blood sample
      • cerebro-spinal fluid
      • Bordeaux, France
        CHU de Bordeaux - service de neurologie
      Feb 2, 2022

      CNS Inflammatory Demyelinating Diseases

      Not yet recruiting
      • Multiple Sclerosis
      • +4 more
      • Intravenous steroid
      • (no location specified)
      Nov 29, 2021

      Multiple Sclerosis, Clinically Isolated Syndrome of Demyelination Trial (Tysabri Injectable Product, Placebo)

      Recruiting
      • Multiple Sclerosis
      • Clinically Isolated Syndrome of Demyelination
      • Tysabri Injectable Product
      • Placebo
      • London, United Kingdom
        Royal London Hospital
      Jan 25, 2023

      MS-ResearchBiomarkerS

      Recruiting
      • Multiple Sclerosis
      • +10 more
        • Los Angeles, California
          Cedars-Sinai Medical Center
        Jan 26, 2022

        Automatic Segmentation Software to Track Lesions in Multiple

        Active, not recruiting
        • Multiple Sclerosis
        • Clinically Isolated Syndrome
        • Analysis of cerebral MRI with automatic segmentation software
        • Nîmes, France
          CHU Nimes
        Dec 15, 2021

        Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Clinically Isolated Syndrome Trial in Hamburg (Understanding MRI in

        Active, not recruiting
        • Multiple Sclerosis
        • +2 more
        • Understanding MRI in MS (website)
        • Control website
        • Hamburg, Germany
          University Medical Centre Hamburg-Eppendorf
        Dec 5, 2022

        Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion Trial in San Francisco (Clemastine

        Not yet recruiting
        • Demyelinating Diseases
        • +4 more
        • Clemastine Fumarate
        • Placebo
        • San Francisco, California
          Sandler Neurosciences Building, Neurological Clinical Research U
        Oct 3, 2023

        Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Clinically Isolated Syndrome Trial in Beirut (Vitamin D3)

        Recruiting
        • Multiple Sclerosis
        • +4 more
        • Vitamin D3
        • Beirut, Lebanon
          Nehme & Therese Tohme Multiple Sclerosis Center
        Aug 27, 2021

        Multiple Sclerosis (MS), Multiple Sclerosis (MS) Relapsing Remitting, Multiple Sclerosis (MS) Primary Progressive Trial in

        Completed
        • Multiple Sclerosis (MS)
        • +6 more
        • Video-oculography / Social cognition tasks / Neuropsychological evaluations
        • Monaco, Monaco
          Centre Mémoire / Centre de Gérontologie Clinique Rainier III / P
        Jan 19, 2021

        Visual Processing Speed and Objective Analysis of Ocular

        Enrolling by invitation
        • Multiple Sclerosis
        • +3 more
        • Eye tracking
        • +3 more
        • Valladolid, Spain
          IOBA - Universidad de Valladolid
        Jan 20, 2023